Keywords: مرگ سلولی برنامه ریزی شده- 1; Nafamostat mesilate; Programmed cell death ligand-1; Interferon-gamma; Programmed cell death-1; Human leukocyte antigen class I; Lung cancer;
مقالات ISI مرگ سلولی برنامه ریزی شده- 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مرگ سلولی برنامه ریزی شده- 1; CA IX; Carbonic anhydrase IX; CAFs; Cancer associated fibroblasts; TAMs; Tumor-associated macrophages; HIF-1; Hypoxia-inducible factor 1; EGFR; Epidermal growth factor receptor; ALDH1; Aldehyde dehydrogenase 1; HSF-1; Heat shock factor-1; PD-L1; Pro
Keywords: مرگ سلولی برنامه ریزی شده- 1; ADA; anti-drug antibodies; AMPK; 5â² adenosine monophosphate-activated protein kinase; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; APC; antigen presenting cells; AT; anaphylatoxin; BTK; Bruton's tyrosine kinase; C1q
Keywords: مرگ سلولی برنامه ریزی شده- 1; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: مرگ سلولی برنامه ریزی شده- 1; Immune-related adverse event; Immunotherapy; Nivolumab; Non-small cell lung cancer; Psoriatic arthritis; Programmed cell death-1;
Keywords: مرگ سلولی برنامه ریزی شده- 1; HLA-G; human leukocyte antigen G; HLA-E; human leukocyte antigen E; PD-L1; programmed cell death 1 ligand 1; IL-10; interleukin-10; TGF-β; transforming growth factor beta; sHLA-G; soluble HLA-G; OL; oral leukoplakia; GB; granzyme B; OPL; oral precancerou
Keywords: مرگ سلولی برنامه ریزی شده- 1; Acute pneumonitis; Afatinib; Anti PD-1 antibody; Immune checkpoint inhibitor; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; PD-1; programmed cell death-1; PD-L1; programmed cell death ligand-1; NSCLC; non-small cell lung cancer; BA
Keywords: مرگ سلولی برنامه ریزی شده- 1; Rheumatoid arthritis; Programmed cell death-1; Lymphocytes; Signaling; Autoimmunity;
Keywords: مرگ سلولی برنامه ریزی شده- 1; Melanoma; Programmed cell death-1; PD-L1; Ipilimumab-refractory; Survival;
Keywords: مرگ سلولی برنامه ریزی شده- 1; Cytotoxic T lymphocyte antigen-4; Programmed cell death-1; Cancer immunotherapy; Tumor immunology; Lymph node; Drug delivery systems; Controlled release; Therapeutic antibody; Immune-related associated toxicity;
Keywords: مرگ سلولی برنامه ریزی شده- 1; lymphoma; pembrolizumab; programmed cell death-1; sarcoidosis; FDG; fludeoxyglucose; PD-1; programmed cell death-1;
Keywords: مرگ سلولی برنامه ریزی شده- 1; Programmed cell death-1; Large retinal ganglion cells; Apoptosis; Optic nerve crush; Neuroprotection;
Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4
Keywords: مرگ سلولی برنامه ریزی شده- 1; PD-L1; Programmed cell death-ligand 1; PD-1; programmed cell death-1; CBIS; cell-based immunization and screening; SCC; squamous cell carcinoma; ACC; adenoid cystic carcinoma; MEC; mucoepidermoid carcinoma; CTLA-4; cytotoxic T-lymphocyte-associated antige
Combining chemotherapy with PD-1 blockade in NSCLC
Keywords: مرگ سلولی برنامه ریزی شده- 1; NSCLC; non-small cell lung cancer; PT-DC; platinum-doublet chemotherapy; ORR; objective response rate; PD-1; programmed cell death-1; PD-L1; programmed death ligand-1; CTLA-4; cytotoxic T-lymphocyte antigen-4; DC; dendritic cell; TME; tumor microenvironme
Overexpression of programmed cell death-1 and human leucocyte antigen-DR on circulatory regulatory T cells in out-of-hospital cardiac arrest patients in the early period after return of spontaneous circulation
Keywords: مرگ سلولی برنامه ریزی شده- 1; Human leucocyte antigen-DR; Out-of-hospital cardiac arrest; Programmed cell death-1; Regulatory T cells;
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
Keywords: مرگ سلولی برنامه ریزی شده- 1; ALK; anaplastic lymphoma kinase; BRAF; v-Raf murine sarcoma viral oncogene homolog B; cMET; tyrosine-protein kinase Met/hepatocyte growth factor receptor; CT; computer tomography; ECOG; PS Eastern Cooperative Oncology Group performance status; EGFR; epide
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
Keywords: مرگ سلولی برنامه ریزی شده- 1; AE; adverse event; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; HR; hazar
PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration
Keywords: مرگ سلولی برنامه ریزی شده- 1; Programmed cell death-1; Myeloid cells; Neuroinflammation; Prion disease;
The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers
Keywords: مرگ سلولی برنامه ریزی شده- 1; Biomarker; Immunotherapy; Non-small-cell lung cancer; Programmed cell death-1; Programmed cell death-ligand 1;
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma
Keywords: مرگ سلولی برنامه ریزی شده- 1; HIFs; hypoxia-inducing factors; RCC; renal cell carcinoma; VHL; von Hippel-Lindau; CTLs; cytotoxic T lymphocytes; mRCC; metastatic renal cell carcinoma; IL; interleukin; IFN; interferon; PD-1; programmed cell death-1; PD-L1; PD-ligand-1; CTLA-4; cytotoxic
Pembrolizumab's non-cross resistance mechanism of action successfully overthrown ipilimumab
Keywords: مرگ سلولی برنامه ریزی شده- 1; Metastatic skin cancer; Programmed cell death-1; Non-cross resistant; BRAF inhibitors; Ipilimumab; Pembrolizumab;
Involvement of Ly6C, 4-1BB, and KLRG1 in the activation of lamina propria lymphocytes in the small intestine of sanroque mice
Keywords: مرگ سلولی برنامه ریزی شده- 1; Costimulation; Inflammation; Intestine; Proinflammatory cytokine; Roquin; ICOS; inducible costimulator; IELs; intraepithelial lymphocytes; KLRG1; killer cell lectin-like receptor subfamily G member 1; LPLs; lamina propria lymphocytes; LCA; leukocyte commo
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients
Keywords: مرگ سلولی برنامه ریزی شده- 1; ALP; Alkaline Phosphatase; ALT; alanine transaminase; AST; aspartate aminotransferase; BSA; Bovine Serum Albumin; CRP; C-Reactive Protein; CV; Coefficient of Variation; ECOG; Eastern Cooperative Oncology Group; EMA; European Medicines Agency; FDA; Food an
Anti-PD-L1 peptide improves survival in sepsis
Keywords: مرگ سلولی برنامه ریزی شده- 1; Therapeutic peptide; Immunomodulatory drug; Programmed cell death-1; Immunosuppression; Sepsis;
Combined blockade of Tim-3 and MEK inhibitor enhances the efficacy against melanoma
Keywords: مرگ سلولی برنامه ریزی شده- 1; Trametinib; Tim-3; MAPK pathway; Targeted therapy; Cancer immunotherapy; MAPK; mitogen-activated protein kinase; MEK; mitogen-activated extracellular signal-regulated kinase; OS; overall survival; CTLA-4; cytotoxic T lymphocyte antigen-4; PD-1; programmed
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
Keywords: مرگ سلولی برنامه ریزی شده- 1; ILD; interstitial lung disease; EGFR; epidermal growth factor receptor; TKIs; tyrosine-kinase inhibitors; PD-1; programmed cell death-1; NSCLC; non-small-cell lung cancer; RECIST; Response Evaluation Criteria in Solid Tumors; CT; chest computed tomography
A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients
Keywords: مرگ سلولی برنامه ریزی شده- 1; Immunohistochemistry; Immunotherapy; Lung cancer; Programmed cell death-1; Programmed cell death ligand-1;
CD4+ and CD8+ T Cell Activation in Children with Hepatitis C
Keywords: مرگ سلولی برنامه ریزی شده- 1; BD; Becton, Dickinson and Company; EOMES; Eomesodermin; HCV; Hepatitis C virus; IFN; Interferon; IL; Interleukin; PBMC; Peripheral blood mononuclear cell; PD-1; Programmed cell death-1; SEB; Staphylococcal enterotoxin B; T-bet; T-box transcription factor
Decreased Programmed Death-1 Expression on the T Cells of Patients With Ankylosing Spondylitis
Keywords: مرگ سلولی برنامه ریزی شده- 1; Ankylosing spondylitis; Programmed cell death-1; T cells; Regulatory T cells;
PD-1 mRNA expression is associated with clinical and viral profile and PD1 3â²-untranslated region polymorphism in patients with chronic HBV infection
Keywords: مرگ سلولی برنامه ریزی شده- 1; Hepatitis B virus; Chronic infection; Programmed cell death-1; 3â²-untranslated region; Single nucleotide polymorphism;
Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: A case-control study
Keywords: مرگ سلولی برنامه ریزی شده- 1; SNP; Single nucleotide polymorphism; HCC; Hepatocellular carcinoma; CI; Confidence interval; OR; Odds ratio; PCR-RFLP; polymerase chain reaction-restriction fragment length polymorphism; Hepatocellular carcinoma; Programmed cell death-1; PD-1.3 polymo
What are regulatory T cells (Treg) regulating in cancer and why?
Keywords: مرگ سلولی برنامه ریزی شده- 1; TGF-β; transforming growth factor beta; nTreg; natural regulatory T cells; iTreg; inducible regulatory T cells; PGE2; prostaglandin E2; COX2; cyclooxygenase 2; TIL; tumor infiltrating lymphocytes; CTL; cytotoxic T lymphocytes; NK cells; natural killer ce
Research ArticleA predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping
Keywords: مرگ سلولی برنامه ریزی شده- 1; HCV; hepatitis C virus; PD-1; Programmed Cell Death-1; Peg-IFN; pegylated interferon; KIR; killer immunoglobulin-like receptors; HLA; human leukocyte antigens; SVR; sustained virological responders; NR; non responders; CTL; cytolytic T lymphocytes; HC; he
Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection
Keywords: مرگ سلولی برنامه ریزی شده- 1; Chronic HBV infection; Programmed cell death-1; Tumor necrosis factor-α; Polymorphism; Interferon-γ;